Literature DB >> 707792

Aluminium phosphate but not calcium phosphate stimulates the specific IgE response in guinea pigs to tetanus toxoid.

T L Vassilev.   

Abstract

The ability of aluminium phosphate and calcium phosphate to stimulate the synthesis of tetanus toxoid-specific anaphilactic and antitoxic antibodies is compared. The observed differences in the kinetics of IgG1a, IgG1b and antitoxines are quantitative--titres after application of aluminium phosphate are higher. Booster immunization with aluminium but not calcium phosphate-adsorbed toxoid leads to a prolonged synthesis of specific IgE. It is hypothesized that the regular application of aluminium compound-containing vaccines on the entire population could be one of the factors leading to the observed increase of allergic diseases.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 707792     DOI: 10.1111/j.1398-9995.1978.tb01527.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  4 in total

Review 1.  Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide.

Authors:  Daniel Krewski; Robert A Yokel; Evert Nieboer; David Borchelt; Joshua Cohen; Jean Harry; Sam Kacew; Joan Lindsay; Amal M Mahfouz; Virginie Rondeau
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2007       Impact factor: 6.393

2.  Calcium phosphate nanoparticle adjuvant.

Authors:  Q He; A R Mitchell; S L Johnson; C Wagner-Bartak; T Morcol; S J Bell
Journal:  Clin Diagn Lab Immunol       Date:  2000-11

3.  Protein coated microcrystals formulated with model antigens and modified with calcium phosphate exhibit enhanced phagocytosis and immunogenicity.

Authors:  Sarah Jones; Catpagavalli Asokanathan; Dorota Kmiec; June Irvine; Roland Fleck; Dorothy Xing; Barry Moore; Roger Parton; John Coote
Journal:  Vaccine       Date:  2013-10-10       Impact factor: 3.641

Review 4.  Unraveling the enigma: elucidating the relationship between the physicochemical properties of aluminium-based adjuvants and their immunological mechanisms of action.

Authors:  Emma Shardlow; Matthew Mold; Christopher Exley
Journal:  Allergy Asthma Clin Immunol       Date:  2018-11-07       Impact factor: 3.406

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.